WBD:NASDAQWarner Bros. Discovery, Inc. - Series A Analysis
Data as of 2026-05-10 - not real-time
$27.11
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Warner Bros. Discovery is trading around $27.11, just above the computed support level of $26.60 and below the near‑term resistance of $27.59. The stock sits in a neutral trend with the 20‑day SMA (≈27.16) barely under the 50‑day SMA (≈27.40) and the 200‑day SMA (≈23.10) providing long‑term support. Technical momentum shows a mid‑range RSI of ~46 and a bullish MACD histogram, suggesting limited downside pressure but no strong upside catalyst. Volume has been decreasing, indicating waning trader interest. Recent earnings disclosed a wider‑than‑expected Q1 loss, driven by a $2.8 billion termination fee to Netflix and flat revenue growth, with a negative profit margin of‑4.7% and a trailing EPS of –$0.70. Despite the earnings miss, the discounted cash‑flow model pins a fair value near $86, implying roughly a 9% upside from the current price. However, the forward PE of ~1,800×, a debt load of $32.5 billion versus $3.3 billion in cash, and a negative ROE underscore significant value‑risk tension. The company does not pay a dividend, so income‑focused investors have no yield cushion. In summary, the stock appears undervalued relative to its DCF estimate but is hampered by weak earnings, high leverage, and a modest technical setup.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering just above support with decreasing volume
- Recent earnings miss and high termination fee impact
- Neutral technical indicators (RSI, MACD) provide limited upside
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- DCF‑based upside of ~9% suggests price mispricing
- Subscriber growth in HBO Max and potential synergies from the Paramount‑Skydance deal
- Improving cash‑flow generation despite current losses
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High debt‑to‑equity ratio limits financial flexibility
- Media industry disruption and competitive pressure
- Long‑term valuation upside tempered by structural earnings challenges
Key Metrics & Analysis
Financial Health
Revenue Growth-1.00%
Profit Margin-4.67%
P/E Ratio1807.3
ROE-4.96%
ROA1.39%
Debt/Equity96.32
P/B Ratio1.9
Op. Cash Flow$3.6B
Free Cash Flow$18.5B
Industry P/E17.2
Technical Analysis
TrendNeutral
RSI46.3
Support$26.60
Resistance$27.59
MA 20$27.16
MA 50$27.40
MA 200$23.10
MACDBullish
VolumeDecreasing
Fear & Greed Index90.73
Valuation
Fair Value$86.40
Target Price$29.65
Upside/Downside9.35%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.85
Volatility9.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.